Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer.
Kong W, Deng B, Shen X, John C, Haag J, Sinha N, Lee D, Sun W, Chen S, Zhang H, Clontz A, Hursting SD, Zhou C, Bae-Jump V.
Kong W, et al.
Gynecol Oncol. 2024 Dec;191:116-123. doi: 10.1016/j.ygyno.2024.10.004. Epub 2024 Oct 10.
Gynecol Oncol. 2024.
PMID: 39388742
Free article.